{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:33:24Z","timestamp":1787315604960,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,20]],"date-time":"2022-11-20T00:00:00Z","timestamp":1668902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jacl.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T02:22:55Z","timestamp":1669083775000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-5422","authenticated-orcid":false,"given":"Shehan D.","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-0522","authenticated-orcid":false,"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-6530","authenticated-orcid":false,"given":"Jacqueline S.","family":"Dron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2022.11.007_bib0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2022.11.007_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-021-01517-6","article-title":"Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study","volume":"20","author":"Berberich","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2022.11.007_bib0003","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0004","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2022.11.007_bib0006","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jacl.2020.01.003","article-title":"The polygenic nature of mild-to-moderate hypertriglyceridemia","volume":"14","author":"Dron","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0010","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1194\/jlr.M079822","article-title":"Polygenic determinants in extremes of high-density lipoprotein cholesterol","volume":"58","author":"Dron","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.11.007_bib0011","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1194\/jlr.P086280","article-title":"Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia","volume":"59","author":"Dron","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.11.007_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12920-020-0669-2","article-title":"Six years\u2019 experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias","volume":"13","author":"Dron","year":"2020","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacl.2022.11.007_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacl.2022.11.007_bib0014","series-title":"Ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jacl.2022.11.007_bib0015","first-page":"326","article-title":"Detection and characterization of the heterozygote state for lipoprotein lipase deficiency","volume":"9","author":"Babirak","year":"1989","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0016","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1016\/S0021-9258(19)39449-9","article-title":"Missense mutation (Gly\u2014-Glu188) of human lipoprotein lipase imparting functional deficiency","volume":"265","author":"Emi","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2022.11.007_bib0017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI114770","article-title":"Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation","volume":"86","author":"Wilson","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.11.007_bib0018","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI116551","article-title":"Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes","volume":"92","author":"Wilson","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2022.11.007_bib0019","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diab.46.12.2063","article-title":"Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency","volume":"46","author":"Julien","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2022.11.007_bib0020","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1002\/humu.1380110150","article-title":"Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population","volume":"1","author":"Julien","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2022.11.007_bib0021","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2022.11.007_bib0022","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1161\/ATVBAHA.107.150680","article-title":"Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650)","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0023","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/hmg\/ddn188","article-title":"Polygenic determinants of severe hypertriglyceridemia","volume":"17","author":"Wang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacl.2022.11.007_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(21)00046-2","article-title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Gouni-Berthold","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(98)70227-6","article-title":"Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents","volume":"133","author":"Gidding","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2022.11.007_bib0026","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cgh.2020.08.016","article-title":"Genetic variants associated with increased plasma levels of triglycerides, via effects on the lipoprotein lipase pathway, increase risk of acute pancreatitis","volume":"19","author":"Hansen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2022.11.007_bib0027","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17512433.2022.2094768","article-title":"Safety and efficacy of therapies for chylomicronemia","volume":"15","author":"Shamsudeen","year":"2022","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287422003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287422003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:37:34Z","timestamp":1761831454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287422003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1933287422003282"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2022.11.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}